Caplin Point Laboratories Ltd 524742
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 1,331.10
- Day Range
- INR 1,295.25–1,339.75
- 52-Week Range
- INR 673.10–1,617.80
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 98.63 Bil
- Volume/Avg
- 3,137 / 9,934
Key Statistics
- Price/Earnings (Normalized)
- 22.56
- Price/Sales
- 6.09
- Dividend Yield (Trailing)
- 0.35%
- Dividend Yield (Forward)
- 0.39%
- Total Yield
- 0.35%
Company Profile
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 63
- Website
- https://www.caplinpoint.net
Comparables
Valuation
|
Metric
|
524742
|
500288
|
506943
|
|---|---|---|---|
Price/Earnings (Normalized) | 22.56 | 33.14 | 56.38 |
Price/Book Value | 4.76 | 3.22 | 10.77 |
Price/Sales | 6.09 | 1.54 | 8.80 |
Price/Cash Flow | 25.68 | 31.42 | 42.80 |
Price/Earnings
524742
500288
506943
Financial Strength
|
Metric
|
524742
|
500288
|
506943
|
|---|---|---|---|
Quick Ratio | 4.03 | 0.95 | 1.81 |
Current Ratio | 5.67 | 2.23 | 2.74 |
Interest Coverage | 631.76 | 30.56 | 15.51 |
Quick Ratio
524742
500288
506943
Profitability
|
Metric
|
524742
|
500288
|
506943
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
524742
500288
506943
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hmbvwxgfc | Mpcdc | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Yrgvrdcpd | Glkmybs | $70.9 Bil | |
HLN
| Haleon PLC ADR | Yhkgqtlz | Jwm | $37.8 Bil | |
VTRS
| Viatris Inc | Dkytqrfv | Knxr | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Yhjcwdhyl | Lwtkn | $12.7 Bil | |
CTLT
| Catalent Inc | Sklfbbvng | Plgyhp | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Mxhlpst | Kbdxn | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Srsbdhsq | Ypfg | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ljwzfbm | Zyqhlbz | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Fhkgrblrm | Dkqx | $3.1 Bil |